These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 9366660)

  • 21. Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial.
    Emslie GJ; Heiligenstein JH; Wagner KD; Hoog SL; Ernest DE; Brown E; Nilsson M; Jacobson JG
    J Am Acad Child Adolesc Psychiatry; 2002 Oct; 41(10):1205-15. PubMed ID: 12364842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.
    Beasley CM; Dornseif BE; Bosomworth JC; Sayler ME; Rampey AH; Heiligenstein JH; Thompson VL; Murphy DJ; Masica DN
    BMJ; 1991 Sep; 303(6804):685-92. PubMed ID: 1833012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD; Holman SL; Sayler ME; Potvin JH
    J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents.
    Emslie GJ; Kennard BD; Mayes TL; Nightingale-Teresi J; Carmody T; Hughes CW; Rush AJ; Tao R; Rintelmann JW
    Am J Psychiatry; 2008 Apr; 165(4):459-67. PubMed ID: 18281410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.
    March J; Silva S; Petrycki S; Curry J; Wells K; Fairbank J; Burns B; Domino M; McNulty S; Vitiello B; Severe J;
    JAMA; 2004 Aug; 292(7):807-20. PubMed ID: 15315995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testosterone versus fluoxetine for depression and fatigue in HIV/AIDS: a placebo-controlled trial.
    Rabkin JG; Wagner GJ; McElhiney MC; Rabkin R; Lin SH
    J Clin Psychopharmacol; 2004 Aug; 24(4):379-85. PubMed ID: 15232328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Randomized, Double-Blind, Placebo-Controlled Trial of Vilazodone in Children and Adolescents with Major Depressive Disorder with Twenty-Six-Week Open-Label Follow-Up.
    Findling RL; McCusker E; Strawn JR
    J Child Adolesc Psychopharmacol; 2020 Jul; 30(6):355-365. PubMed ID: 32460523
    [No Abstract]   [Full Text] [Related]  

  • 28. Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study.
    Smith WT; Londborg PD; Glaudin V; Painter JR
    Am J Psychiatry; 1998 Oct; 155(10):1339-45. PubMed ID: 9766764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and Efficacy of Levomilnacipran Extended Release in Pediatric Patients Aged 7-17 Years with Major Depressive Disorder: Results of Two Phase 3, Randomized, Double-Blind Studies.
    Radecki DT; Robieson WZ; Gopalkrishnan M; Greenberg E; Aziz M
    J Child Adolesc Psychopharmacol; 2024 Jun; 34(5):241-250. PubMed ID: 38700708
    [No Abstract]   [Full Text] [Related]  

  • 30. Response patterns of depressed outpatients with and without melancholia: a double-blind, placebo-controlled trial of fluoxetine versus placebo.
    Heiligenstein JH; Tollefson GD; Faries DE
    J Affect Disord; 1994 Mar; 30(3):163-73. PubMed ID: 8006243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How long to onset of antidepressant action: a meta-analysis of patients treated with fluoxetine or placebo.
    Tollefson GD; Holman SL
    Int Clin Psychopharmacol; 1994; 9(4):245-50. PubMed ID: 7868846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
    Nemeroff CB; Thase ME;
    J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluoxetine versus trazodone in the treatment of outpatients with major depression.
    Debus JR; Rush AJ; Himmel C; Tyler D; Polatin P; Weissenburger J
    J Clin Psychiatry; 1988 Nov; 49(11):422-6. PubMed ID: 3053668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of extended evaluation on depressive symptoms in children and adolescents.
    Rintelmann JW; Emslie GJ; Rush AJ; Varghese T; Gullion CM; Kowatch RA; Hughes CW
    J Affect Disord; 1996 Nov; 41(2):149-56. PubMed ID: 8961043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo.
    Stewart JW; Quitkin FM; McGrath PJ; Amsterdam J; Fava M; Fawcett J; Reimherr F; Rosenbaum J; Beasley C; Roback P
    Arch Gen Psychiatry; 1998 Apr; 55(4):334-43. PubMed ID: 9554429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy and safety of a new enteric-coated formulation of fluoxetine given once weekly during the continuation treatment of major depressive disorder.
    Schmidt ME; Fava M; Robinson JM; Judge R
    J Clin Psychiatry; 2000 Nov; 61(11):851-7. PubMed ID: 11105738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial.
    Jarrett RB; Schaffer M; McIntire D; Witt-Browder A; Kraft D; Risser RC
    Arch Gen Psychiatry; 1999 May; 56(5):431-7. PubMed ID: 10232298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical response predictors in a double-blind, placebo-controlled trial of fluoxetine for geriatric major depression. Fluoxetine Collaborative Study Group.
    Small GW; Hamilton SH; Bystritsky A; Meyers BS; Nemeroff CB
    Int Psychogeriatr; 1995; 7 Suppl():41-53. PubMed ID: 8580391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind trial of fluoxetine, 20 mg, and placebo in out-patients with DSM-III-R major depression and melancholia.
    Heiligenstein JH; Tollefson GD; Faries DE
    Int Clin Psychopharmacol; 1993; 8(4):247-51. PubMed ID: 8277143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the Hamilton Depression Rating Scale factors from a double-blind, placebo-controlled trial of fluoxetine in geriatric major depression.
    Tollefson GD; Holman SL
    Int Clin Psychopharmacol; 1993; 8(4):253-9. PubMed ID: 8277144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.